Parkinson’s Disease (PD) is the neurodegeneration of pathways in the brain that are critical for action selection and movement control. Such pathways are also vital for the distribution of dopamine and serotonin, the neurotransmitters that control our mood. The disruption of information usually communicated by dopamine and serotonin are highly demonstrated as causative factors of anxiety in previous research.
The AND-PD project will investigate the impact of PD on such pathways in the brain to further understand the functional and pathological changes caused by the disease. Providing new insights to advance personalised treatment of PD patients and open new research avenues supporting prevention, diagnosis and management of co-morbidities in PD patients.